Monthly eNewsletter

Click Here to view and subscribe to LDM Group’s eDigest. A monthly eNewsletter which contains updates on the EMR, EHR, eRx and healthcare industries.

Newsletter Archives

Industry News

New Initiative to Improve Medication Adherence Unveiled By Health Care, Consumer, Patient and Industry Leaders - MarketWatch
A partnership representing patients, health care providers, pharmacy organizations, consumers and health care industry leaders announced a major new initiative today to help improve medication adherence rates. The group, which was formed to advance solutions that help reduce health care costs and improve patient health across the nation, also released the findings of a new national survey conducted by Greenberg Quinlan Rosner Research and Public Opinion Strategies.
Read More

LDM Group Receives EHR Module Certification Of Its Software Application
LDM Group, LLC (LDM), a leading healthcare communications company, announced today that its LDM ConnectSys® 3.0 software application has achieved 2014 Edition Ambulatory and Inpatient EHR Module Certifications by ICSA Labs, an Authorized Certification Body (ACB) of the Office of the National Coordinator for Health Information Technology (ONC) under the American Recovery and Reinvestment Act (ARRA).
Read More

New Life Sciences Trade Group To Focus On Point of Care
A group of leading suppliers of life science marketing and educational services has banded together to form DecisionPoint: The Point of Care Communications Association. The new, nonprofit trade association will focus on educating life science and pharmaceutical companies about the value, benefits and proper use of point of care communications available for both patient and provider education.
Read More

Many Doctors Agree When Patients Ask For Brand-Name Rx: Study
Physicians are more likely to prescribe brand-name drugs over generics when patients request them or when they have contacts with pharmaceutical company representatives, according to researchers. About four in every 10 physicians report they at least sometimes comply with requests for the branded version of a drug when a generic is available, the study stated
Read More

Optimizing Physician and Patient Communication
How pharma marketers can use E-Prescribing, Electronic Medical Records and Electronic Health Records to increase the value of their Point of Care communications.
Read More

DELIVERING BRAND MESSAGES: E-Prescribing/EMR Division
Few things have affected the day-to-day practice of medicine in the physician’s office as much as the recent surge in the use of electronic medical records and e-prescribing systems. LDM Group’s E-prescribing/EMR Division has become a leader in this new channel of communication, producing innovations and services for both physicians and patients that others thought were impossible to deliver.
Read More

Americans Want Greater Control Over Their Own Healthcare
According to a new Wolters Kluwer Health survey, 80 percent of consumers believe the greater “consumerization” of healthcare – or the trend of individuals taking a greater and more active role in their own healthcare – is positive for Americans. Survey data suggests many Americans feel that a greater role in their care is not only good, but necessary, with 86 percent of consumers reporting that they feel they have to take a more proactive role in managing their own healthcare in order to ensure better quality of care.
Read More

Health care "extenders" prefer paper for patient ed, study shows
Nurse practitioners, diabetes educators, registered dietitians, social workers and other health care providers who educate patients on diagnoses and prescription adherence say they prefer educational materials in paper form, according to communications agency HealthEd Group, something marketers should keep in mind when designing materials. Read More

Drug Companies Need To Push For Medication Adherence
Pharmaceutical companies lose an estimated $188 billion annually in revenues in the U.S. because patients fail to take their prescribed medications, according to a study by consulting firm Capgemini. That’s a massive waste of money for an industry experiencing patent expirations and few breakthrough drugs. Read More